Suppr超能文献

备解素途径的分子概念。

A molecular concept of the properdin pathway.

作者信息

Medicus R G, Schreiber R D, Götze O, Müller-Eberhard H J

出版信息

Proc Natl Acad Sci U S A. 1976 Feb;73(2):612-6. doi: 10.1073/pnas.73.2.612.

Abstract

The sequential events of the properdin system were analyzed. Properdin-depleted serum allows the formation of a Factor B- and D-dependent C3 convertase. This enzyme, called the properdin-receptor-forming enzyme, was shown to utilize a novel serum component, the initiating factor. The protein is a beta-globulin in precursor form and is distinct from immunoglobulins. The function of the enzyme is to deposit C3b on the surface of activator particles. Apparently doublets of C3b are required for the formation of the properdin-activating principle. It consists of a complex containing surface-bound C3b and activated Factor B. properdin precursor is activated by binding to this complex without detectable change in molecular weight. The transition of properdin precursor to activated properdin is probably caused by a conformational change. The complex, consisting of bound C3b, properdin, and activated Factor B, represents the enzyme that acts on C5, thereby initiating self-assembly of the membrane attack system. Native C3 is not needed for the function of the enzyme. It is disassembled by soluble C3 or C3b and its formation is under the control of the properdin-receptor-destroying enzyme, which may be identical with the C3b inactivator.

摘要

分析了备解素系统的一系列事件。缺乏备解素的血清可形成一种依赖于B因子和D因子的C3转化酶。这种酶被称为备解素受体形成酶,已证明它利用一种新的血清成分,即起始因子。该蛋白是前体形式的β球蛋白,与免疫球蛋白不同。该酶的功能是将C3b沉积在激活剂颗粒的表面。显然,C3b的双重体是形成备解素激活原理所必需的。它由一个包含表面结合的C3b和活化的B因子的复合物组成。备解素前体通过与该复合物结合而被激活,分子量无明显变化。备解素前体向活化备解素的转变可能是由构象变化引起的。由结合的C3b、备解素和活化的B因子组成的复合物代表作用于C5的酶,从而启动膜攻击系统的自我组装。该酶的功能不需要天然C3。它被可溶性C3或C3b分解,其形成受备解素受体破坏酶的控制,该酶可能与C3b灭活剂相同。

相似文献

1
A molecular concept of the properdin pathway.备解素途径的分子概念。
Proc Natl Acad Sci U S A. 1976 Feb;73(2):612-6. doi: 10.1073/pnas.73.2.612.
5
Properdin: initiation of alternative complement pathway.备解素:替代补体途径的起始因子
Proc Natl Acad Sci U S A. 1975 Aug;72(8):3220-4. doi: 10.1073/pnas.72.8.3220.

引用本文的文献

4
Structural basis for therapeutic inhibition of complement C5.补体C5治疗性抑制的结构基础
Nat Struct Mol Biol. 2016 May;23(5):378-86. doi: 10.1038/nsmb.3196. Epub 2016 Mar 28.

本文引用的文献

10
C3 proactivator convertase and its mode of action.C3 前活化剂转化酶及其作用方式。
J Exp Med. 1972 Apr 1;135(4):1003-8. doi: 10.1084/jem.135.4.1003.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验